SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

VFX Visionflex Group Limited

Healthcare · Health Information Services · website
$0.04
52wk 0.03 – 0.15
Overall
23.6
Value
72.7
Growth
0.0
Health
7.2
Quality
34.8
Momentum
0.4
Dividend
—
Price
About Visionflex Group Limited

Visionflex Group Limited, together its subsidiaries, engages in the provision of healthcare, telehealth, and remote diagnostic solutions in Australia. It operates through Visionflex and Corporate head office segments. The company offers Virtual healthcare solutions and peripheral medical devices that integrate into proprietary developed software for remote diagnostics and patient care. It serves primary health networks, local health districts, residential aged care facilities, aboriginal community-controlled health organisations, and private healthcare organisations. The company was formerly known as 1st Group Limited and changed its name to Visionflex Group Limited in November 2023. Visionflex Group Limited was incorporated in 2009 and is based in Warriewood, Australia.

Price analytics

Returns

1 day 0.0%
1 week -10.0%
1 month -34.5%
3 months -34.5%
6 months -48.6%
1 year -76.0%
3 years -91.3%

Risk

Volatility (1y ann.) 145.1%
Beta vs ASX 200 0.38
Sharpe (1y) -0.35
VaR 95% (1-day) -15.0%
Max drawdown (1y) -77.3%
Off 1-year high -76.0%

Technicals

RSI(14) 0 OS
vs 50DMA -24.1%
vs 200DMA -43.9%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 72.7
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
0
Price / Sales
100
Growth 0.0
Revenue growth (1y)
0
Revenue CAGR (3y)
0
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 7.2
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
14
Debt / Equity
—
Quality (Profitability & Cash Flow) 34.8
Return on equity
—
Return on assets
0
Operating margin
100
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 0.4
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
2

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$3.12M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
-0.02
EV / EBITDA
-5.41
Price / Book
18.00
ROE
—
Operating margin
45.5%
Net margin
-1.4%
Total cash
$1.62M
Total debt
$577,989
Current ratio
1.04
Debt / Equity
—
Free cash flow
$-288,577
Avg volume
31,020
Latest annual results (FY ending 30 Jun 2026)
  • Revenue$4.14M
  • Gross profit$3.55M
  • Operating income-$2.11M
  • Net income-$57.80K
  • Diluted EPS—
  • Free cash flow-$1.27M
  • Net debt-$1.04M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4